Posts Tagged: California Stem Cell Agency

News

Amidst morale ‘crisis,’ CA stem cell agency could take months to find new president

The Sue and Bill Gross Stem Cell Research building at University of California Irvine, a CIRM major facility. Photo courtesy of CIRM

California’s $12 billion stem cell and gene therapy program could be treading water for the next 12 months in the view of at least one of its leaders as it searches for a new president of the 19-year-old enterprise. Past presidential searches have been burdened by a legal, dual executive arrangement that has been described by a former board member as a “dog’s breakfast.”

News

Stem cell agency down to last $67 million

Blood cells in a bone marrow smear, examined as part of stem cell research. (Photo: toeytoey, via Shutterstock)

California’s state stem cell agency is down to its last $67.3 million following a decision Thursday to back research to enhance bone healing in elderly patients who undergo spinal surgery. The $4 million award went to Ankasa Regenerative  Therapeutics following little discussion among members of the governing board of the $3 billion California Institute for Regenerative Medicine.

News

Trump, fetal tissue and California’s stem cell agency

Human fetal placenta under high magnification. (Photo: photowind, via Shutterstock

The California stem cell agency says the Trump administration’s moves against research involving fetal tissue have had no impact on the projects that it is financing, at least so far. The agency, formally known as the California Institute for Regenerative Medicine (CIRM), was responding to a question originally raised by a reader of the California Stem Cell Report.

News

$5 billion stem cell bond scrapped for 2018 ballot

A photo illustration of human DNA. (Photo: Shutterstock)

Plans to ask California voters in 2018 to approve a $5 billion bond issue to finance the California stem cell agency have been shelved, a director of the agency said Thursday. Jeff Sheehy, a San Francisco county supervisor, said that the key backer of the proposal had informed him that no bond measure would be offered to voters before 2020, presumably at the presidential general election.

News

Stem cell: Knee arthritis in new $33 million research plan

A Liquid Nitrogen bank containing a suspension of stem cells. (Photo: Elena Pavlovich)

The California stem cell agency this week approved nearly $33 million for clinical stage research projects testing treatments for type 1 diabetes, arthritis of the knee, ALS and an immunodeficiency affliction.

Support for Capitol Weekly is Provided by: